295 related articles for article (PubMed ID: 7119445)
1. Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease.
Steinhauer EH; Doyle AT; Reed J; Kadish AS
J Immunol; 1982 Nov; 129(5):2255-9. PubMed ID: 7119445
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cell activity and autologous tumor killing activity in cancer patients: overlapping involvement of effector cells as determined in two-target conjugate cytotoxicity assay.
Uchida A; Yanagawa E
J Natl Cancer Inst; 1984 Nov; 73(5):1093-100. PubMed ID: 6593485
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
4. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
5. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
6. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
Uchida A; Moore M
J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single-cell cytotoxicity assays.
Gregory CD; Lee H; Rees GB; Scott IV; Shah LP; Golding PR
Clin Exp Immunol; 1985 Oct; 62(1):121-7. PubMed ID: 3864569
[TBL] [Abstract][Full Text] [Related]
8. Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics.
Bloom ET; Babbitt JT; Kawakami K
J Immunol; 1986 Jul; 137(1):172-8. PubMed ID: 3711665
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cell-mediated antitumor reactivity of rhesus monkeys.
Savary CA; Lotzová E; Gray KN; Jardine JH
Nat Immun Cell Growth Regul; 1985; 4(6):328-39. PubMed ID: 3878943
[TBL] [Abstract][Full Text] [Related]
10. [Studies on the mechanism of defective natural killer cytotoxicity in patients with multiple myeloma].
Funato T; Koide A; Ohtani H; Saito M
Gan No Rinsho; 1984 Apr; 30(4):368-72. PubMed ID: 6727037
[TBL] [Abstract][Full Text] [Related]
11. Surface markers and cytotoxic activity of blood natural killer cells studied at the single cell level in Hodgkin's disease.
Jezewska E; Björkholm M; Giscombe R; Holm G; Tullgren O
Clin Exp Immunol; 1985 Jul; 61(1):96-102. PubMed ID: 4042422
[TBL] [Abstract][Full Text] [Related]
12. Generation of suppressor cells for natural killer activity in cancer patients after surgery.
Uchida A; Kolb R; Micksche M
J Natl Cancer Inst; 1982 May; 68(5):735-41. PubMed ID: 6461792
[TBL] [Abstract][Full Text] [Related]
13. Changes in number and density of large granular lymphocytes upon in vivo augmentation of mouse natural killer activity.
Santoni A; Piccoli M; Ortaldo JR; Mason L; Wiltrout RH; Herberman RB
J Immunol; 1985 Apr; 134(4):2799-810. PubMed ID: 2579157
[TBL] [Abstract][Full Text] [Related]
14. Defective NK cell activity following thermal injury.
Klimpel GR; Herndon DN; Fons M; Albrecht T; Asuncion MT; Chin R; Stein MD
Clin Exp Immunol; 1986 Nov; 66(2):384-92. PubMed ID: 3493101
[TBL] [Abstract][Full Text] [Related]
15. Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity.
Luger TA; Uchida A; Köck A; Colot M; Micksche M
J Immunol; 1985 Apr; 134(4):2477-83. PubMed ID: 3882831
[TBL] [Abstract][Full Text] [Related]
16. Increased number of functionally defective large granular lymphocytes in lymphoma patients.
Muhonen T; Teerenhovi L; Saksela E
Nat Immun Cell Growth Regul; 1987; 6(2):57-64. PubMed ID: 3600676
[TBL] [Abstract][Full Text] [Related]
17. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B
J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
[TBL] [Abstract][Full Text] [Related]
18. Human large granular lymphocytes: spontaneous and interferon-boosted NK activity against adherent and nonadherent tumor cell lines.
de Landazuri MO; López-Botet M; Timonen T; Ortaldo JR; Herberman RB
J Immunol; 1981 Oct; 127(4):1380-3. PubMed ID: 6168686
[TBL] [Abstract][Full Text] [Related]
19. Decreased natural killer activity in thalassemia major: a possible consequence of iron overload.
Akbar AN; Fitzgerald-Bocarsly PA; de Sousa M; Giardina PJ; Hilgartner MW; Grady RW
J Immunol; 1986 Mar; 136(5):1635-40. PubMed ID: 3005397
[TBL] [Abstract][Full Text] [Related]
20. The role of interleukin 1 (IL 1) in tumor-NK cell interactions: correction of defective NK cell activity in cancer patients by treating target cells with IL 1.
Herman J; Dinarello CA; Kew MC; Rabson AR
J Immunol; 1985 Oct; 135(4):2882-6. PubMed ID: 2993420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]